Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.
about
Polycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age WomenHistory of infertility and risk of type 2 diabetes mellitus: a prospective cohort studyPolycystic ovary syndrome: aggressive or protective factor for the retina? Evaluation of macular thickness and retinal nerve fiber layers using high-definition optical coherence tomographyPhysical Properties of Blood Are Altered in Young and Lean Women with Polycystic Ovary SyndromeEvaluation of Relationship between Body Mass Index with Vitamin D Receptor Gene Expression and Vitamin D Levels of Follicular Fluid in Overweight Patients with Polycystic Ovary Syndrome.Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study.Screening for dysglycaemia by oral glucose tolerance test should be recommended in all women with polycystic ovary syndrome.Implications of circulating irisin and Fabp4 levels in patients with polycystic ovary syndrome.Serum betatrophin levels are increased and associated with insulin resistance in patients with polycystic ovary syndrome.The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS.Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.Prediabetes and diabetes in a cohort of Qatari women screened for polycystic ovary syndrome.Assessment of circulating betatrophin concentrations in lean glucose-tolerant women with polycystic ovary syndrome.Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
P2860
Q27021307-C0884E42-0309-4376-8459-1A194264D395Q28392981-AE4E5E36-855A-4D9A-AB5A-3289D289CC30Q35119580-C0647AB9-75F0-45AC-B74E-BE50095A7AA8Q36208271-F4B90E75-A49E-4E1A-BFE2-C56024BD275CQ37695793-91E1FA45-4C94-4765-86B9-0AB6D3C1DAAEQ40404052-B88B3FD7-7BC6-48AF-8738-C72CE85D898AQ40705399-948DEB85-9688-4791-AD10-2A0F595E88C0Q40752035-745AE15C-7822-4D69-B34F-6F5B220E24B7Q42340162-3BB65315-59A4-453D-9B14-EDF85E53D503Q47181603-FDD9ECBD-3D81-4A5C-B0F0-15616C4CFE2DQ47402228-9D889709-DD4C-4A7E-B5C6-2200863F7281Q50347800-2D99F642-A67C-4699-9255-D929F086DE84Q51093557-52702E68-4EF6-42D5-889A-5B7E21DDBB0EQ51298340-4B7013E7-CAA8-4D2E-8D71-B46D5F554090
P2860
Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Progression to impaired glucos ...... a controlled follow-up study.
@en
Progression to impaired glucos ...... a controlled follow-up study.
@nl
type
label
Progression to impaired glucos ...... a controlled follow-up study.
@en
Progression to impaired glucos ...... a controlled follow-up study.
@nl
prefLabel
Progression to impaired glucos ...... a controlled follow-up study.
@en
Progression to impaired glucos ...... a controlled follow-up study.
@nl
P2093
P1476
Progression to impaired glucos ...... : a controlled follow-up study
@en
P2093
Murat Yilmaz
Nicel Tasdemir
Remzi Abali
P304
P356
10.1016/J.FERTNSTERT.2013.12.050
P407
P50
P577
2014-02-04T00:00:00Z